Assessment of serum calcium levels and its outcome among transfusion dependent beta thalassemia major patients on chelation therapy
DOI:
https://doi.org/10.55629/pakjpathol.v36i3.944Abstract
Objective: To analyze the serum calcium levels and its outcome among blood transfusion dependent β-Thalassemia major patients on chelation therapy.
Material and Methods: cross-sectional study design was employed to conduct the study. A total of 250 children diagnosed (5-12 years old) with beta thalassemia major undergoing regular blood transfusions, presented to the pediatric ward of CMH Bahawalpur between June 2024 and June 2025 were included in the study. The approval of the ethical review board and written informed consent of the respondents and their guardians were obtained for conducting the study. The patients with their guardians were then approached for data collection. Laboratory analysis of the fresh blood samples of the patients, under aseptic measures, was conducted for serum calcium levels with the documentation of results.
Results: This study found a significant association between hypocalcemia and the occurrence of clinical symptoms in transfusion dependent thalassemia patients. Carpopedal spasm (4.5%), numbness (13.4%), bone pain (46.3%), and fractures (19.4%) were observed exclusively in patients with hypocalcemia, while none of these symptoms were present in those with normocalcemia. The associations were statistically significant, with p-values < 0.05 for all variables except seizures, which were not reported in either group.
Conclusion: Hypocalcemia was significantly associated with carpopedal spasm, numbness, bone pain, and fractures in transfusion-dependent thalassemia patients, with females showing a higher burden of complications. Regular calcium monitoring is essential to reduce morbidity in this population.
Keywords: Beta thalassemia, Blood transfusion, Chelation therapy, Hypocalcemia.
References
Langer AL, Esrick EB. β-Thalassemia: Evolving treatment options beyond transfusion and iron chelation. Hematol. 2021; 2021(1): 600-6. DOI: https://doi.org/10.1182/hematology.2021000313
Khaliq S. Thalassemia in Pakistan. Hemoglobin. 2022; 46(1): 12-4. DOI: https://doi.org/10.1080/03630269.2022.2059670
Lulla HS, Lakhani SL, Patil SD, Chaudhry H, Warthe VM. Blood transfusion complications prevalence parametric causes for stress of disease and management of transfusion dependent thalassemia: A narrative review. World J Pharm Res. 2020; 9 (7): 1192-220. Available from: https://www.wisdomlib.org/ uploads/journals/wjpr/volume-9,-july-issue-7_1472 3.pdf
Majumder A, Basu S. Hypoparathyroidism in a case of transfusion dependent thalassemia. Journal of the ASEAN Fed Endocrine Soc. 2020; 35(1): 129-32. DOI: https://doi.org/10.15605/jafes.035.01.23
Strain JJ, Cashman KD. Minerals and trace elements. Introduction to human nutrition. 2009; 24: 188.
DOI: https://doi.org/10.1002/9781394322428.ch11
Moustafa SR, Kadhem Al-Hakeim H, Alhillawi ZH, Maes M. In transfusion-dependent thalassemia children, increased iron overload is associated with lower serum alpha-klotho, which is strongly associated with lower total and ionized calcium concentrations. Curr Mol Med. 2023; 23(5): 442-52. DOI: https://doi.org/10.2174/15665240226662 20607163232
Theppornpitak K, Trakarnsanga B, Lauhasurayotin S, Poparn H, Chiengthong K, Sosothikul D, et al. A study to assess and improve adherence to iron chelation therapy in transfusion-dependent thalassemia patients. Hemoglobin. 2021; 45(3): 171-4. DOI: https://doi.org/10. 1080/03630269.202 1.1934010
Orhan Ö, Demir H, Talay MN, Özgün N, Özbek MN. Evaluation of children and adolescents with thalassemia major in terms of osteoporosis: A single-centre experience. J Clin Med. 2025; 14(5): 1579. DOI: https://doi.org/10.3390/jcm14051579
Sastry UM, Ray S, Chandra J, Sharma S. Prevalence and correlates of hypocalcemia in transfusion dependent thalassemia. Pediatr Hematol Oncol J. 2020; 5(3): 83–87. DOI: https://doi.org/10.1016/j.phoj.2020.05.001
Catalano A, Chilà D, Bellone F, et al. Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? J Clin Transl Endocrinol. 2018; 13: 9-13. DOI: https://doi.org/10.1016/j.jcte.2018.05.004
Sultan S, Irfan SM, Ahmed SI. Biochemical Markers of bone turnover in patients with β‐thalassemia major: A single center study from southern Pakistan. Adv Hematol. 2016(1): 5437609. DOI: https://doi.org/10.1155/2016/5437609
Shah S. Assessment of serum calcium and phosphorus levels among transfusion-dependent beta thalassemia major patients on chelation therapy. J Postgrad Med Inst. 2015; 29(3): 168-71. Available from: https://jpmi.org.pk/index.php/ jpmi/article/view/1732
Mirhosseini NZ, Shahar S, Ghayour-Mobarhan M, Banihashem A, Kamaruddin NA, Hatef MR, et al. Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents. J Bone Mineral Metab. 2013; 31(4): 468-76. DOI: https://doi.org/10.1007/s00774-013-0433-1
Bou-Fakhredin R, Motta I, Cappellini, MD, Taher AT. Clinical complications and their management. Hematol Oncol Clin N Am. 2023; 37: 365–78. DOI: https://doi.org/10.1016/j.hoc.2017.11.005
Galanello R, Origa R. Beta-thalassemias. Orphanet J Rare Dis. 2010; 15(1): 69. DOI: https://doi.org/10.1186/1750-1172-5-11
De Virgillis S, Congia M, Frau F, Argiolu F, Diana G, Cucca F, et al. Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr. 1988; 113(4): 661-9. DOI: https://doi.org/10.1016/s0022-3476(88)80375-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Kaynat Ali, Sohail Shahzad, Farooq Ahmed, Naila Hamid, Hina Basharat, Huzaifa Usman

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
